CHRW
44
-3
RIG
35
4
PEG
65
22
THC
73
3
BLK
63
-3
M
30
-6
EMR
50
3
AVY
68
-3
PX
62
2
SYF
86
-4
MA
58
-9
CA
36
4
RL
73
-2
AEE
50
2
AN
43
2
WU
28
-2
CSCO
54
3
SRCL
60
3
MO
42
-6
UNM
61
2
CHRW
44
-3
RIG
35
4
PEG
65
22
THC
73
3
BLK
63
-3
M
30
-6
EMR
50
3
AVY
68
-3
PX
62
2
SYF
86
-4
MA
58
-9
CA
36
4
RL
73
-2
AEE
50
2
AN
43
2
WU
28
-2
CSCO
54
3
SRCL
60
3
MO
42
-6
UNM
61
2
Financhill
Back

LPL Financial Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
62

LPLA
LPL Financial Holdings

Last Price:
279.13
Seasonality Move:
3.47%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Buy
62
LPL Financial Holdings (LPLA) is a Buy

Is LPL Financial Holdings a Buy, Sell or Hold?

  • The current LPL Financial Holdings [LPLA] share price is $276.41. The Score for LPLA is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • LPLA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LPLA Stock Price Chart

What is LPL Financial Holdings's stock price today?

  • The LPL Financial Holdings share price today is $276.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LPLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

LPLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.84 Buy
Relative Strength Index (14 RSI): 47.98 Sell
Chaikin Money Flow: 216603 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (276.37 - 284.23) Sell
Bollinger Bands (100): (257.97 - 277.07) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

LPLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 279.68 Sell
20-day SMA: 280.65 Sell
50-day SMA: 273.71 Buy
200-day SMA: 248.86 Buy
8-day EMA: 278.17 Sell
20-day EMA: 278.55 Sell
50-day EMA: 274.24 Buy
200-day EMA: 253.56 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

LPL Financial Holdings Earnings Growth & LPLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.98 per share, an increase this year of $0.49 per share, and an increase next year of $3.78 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

LPL Financial Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):